ISBN: 9780243586332 - national cancer institute annual report, vol. 2: october 1, 1989, through september 30, 1990 (classic reprint) (4 Ergebnisse)

- Softcover
Anbieter: Bulrushed Books, Moscow, ID, USABulrushed Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Gebraucht - Wie neu
EUR 28,46
EUR 8,02 VersandVersand innerhalb von USAAnzahl: 1 verfügbar
Zustand: Like New. In unused condition, may show some slight shelf wear, but otherwise unread. This title was digitally scanned from a rare, out of print edition, and will have some visual artifacts from that process.

- Softcover
Anbieter: PBShop.store US, Wood Dale, IL, USAPBShop.store US
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 38,55
Versand gratisVersand innerhalb von USAAnzahl: 15 verfügbar
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

- Softcover
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes KönigreichPBShop.store UK
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 33,21
EUR 7,01 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 15 verfügbar
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

- Softcover
- Print-on-Demand
Anbieter: Forgotten Books, London, Vereinigtes KönigreichForgotten Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 24,05
Versand gratisVersand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
Paperback. Zustand: New. Print on Demand. This book presents a comprehensive analysis of the Cancer Therapy Evaluation Program (CTEP), a vital component of the National Cancer Institute (NCI). The CTEP plays a crucial role in coordinating and monitoring clinical trials for cancer treatments, ensuring the safety and effectiveness of new therapies. The author provides a detailed account of the CTEP's history, structure, and functions, highlighting its impact on cancer research and patient care. Through the examination of various case studies, the book demonstrates the CTEP's rigorous approach to clinical trial design, data analysis, and regulatory oversight. The author also explores the challenges faced by the CTEP, including the need for efficient trial designs, effective communication with the medical community, and maintaining a balance between scientific rigor and patient safety. This book serves as a valuable resource for researchers, clinicians, and policymakers involved in cancer treatment development, offering insights into the complexities and importance of clinical trial evaluation in advancing the fight against cancer. This book is a reproduction of an important historical work, digitally reconstructed using state-of-the-art technology to preserve the original format. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in the book. print-on-demand item. …